| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Swim Across America Since 1987, we've granted nearly $100M to cancer research. For over three decades, Swim Across America has been giving hope by granting nearly $100 million dollars from its charity swims to fund cancer research and clinical trials. Learn more at swimacrossamerica.org Cancer research, Cancer clinical trials, Cancer Investigation, Swimming, Fundraiser, and Non-Profit | 6 | 3 | 6 | 58 |
 |  Horsepower Technologies Horsepower TechnologiesTM is an animal healthcare and technology company dedicated to combating equine lameness through the commercialization of products that reduce its incidence as well as the rehabilitation times associated with lameness. Horsepower Technologies first product, FastTrackTM, is the world’s first rehabilitative orthotic for horses which enables safer and early return to exercise during lameness rehabilitation. FastTrackTM is designed to help rehabilitate horses that have sustained “flexor apparatus” injuries; a series of tendons and ligaments running down the back of the leg. Based on years of innovation and extensive research, FastTrackTM has scientifically demonstrated that it can limit excessive extension … Type: | 1 | 0 | 1 | 2 |
 |  VetStem, Inc. Leading the way in Regenerative Veterinary Medicine Since its formation in 2002, VetStem has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, VetStem pioneered the use of regenerative stem cells in veterinary medicine; VetStem holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In January of 2004 the first horse was treated with VetStem Regenerative Cell Therapy for a tendon injury that would normally have been career ending. By … Type: | 0 | 0 | 0 | 23 |
 | D.tec International Ltd. DrugWipe is the global leader for police roadside driver drug screening and is also used extensively in the workplace. D.tec International founded in 1996 are experts in the provision of Drug and Alcohol screening services for both blue chip companies and the public sector. Drug and Alcohol Screening Solutions, Drug and Alcohol Policy Construction, Drug and Alcohol Awareness Training, Health and Safety, Drug Screening, and Alcohol Screening Type: | 0 | 0 | 0 | 8 |
 | Proteus Digital Health, Inc Healthcare for everyone, everywhere. Welcome to Proteus Digital Health, a leading innovator spearheading the Digital Medicines revolution. Join our unique collection of innovative engineers, scientists, designers, developers, clinicians, and other digital health pioneers, and assist us with achieving our compelling vision, “Healthcare for Everyone, Everywhere.” Proteus is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicine includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicine is to empower … Type: | 9 | 2 | 2 | 65 |
 | Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology, ELUTYXTM. Ocular Therapeutix has built a robust product pipeline of drug delivery solutions developed to reduce the complexity and burden of the current standard of care and position itself to become a leader in the ophthalmic space. Ocular Therapeutix has a commercially available drug product, DEXTENZA® (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use. DEXTENZA is an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following … Type: | 2 | 0 | 1 | 288 |
 | Cue Health Empowering people to live their healthiest lives through personalized, proactive, and informed healthcare. Cue is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. Cue's mission is to empower people to live their healthiest lives through personalized, proactive, and informed healthcare. Cue enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue's first-of-its-kind COVID-19 test was the first FDA-authorized … Type: | 11 | 3 | 9 | 470 |
 | SDI On October 31, 2011, IMS Health completed the purchase of SDI Health, a Pennsylvania-based healthcare market insights and analytics firm. The acquisition brings together both companies’ considerable patient, specialty and managed markets information assets and services capabilities to provide a full, 360-degree view of the entire patient experience. IMS is now positioned to deliver more innovative and comprehensive information services to a broader set of stakeholders, including pharma manufacturers, public and private payers, healthcare providers, pharmacies and healthcare institutions, and other key constituents. ABOUT IMS IMS Health is the leading provider of information, services and technology for the healthcare industry … Type: | 2 | 0 | 1 | 366 |
 | Cancer Support Community CSC uplifts and strengthens people impacted by cancer by providing support and fostering compassionate communities. CSC uplifts and strengthens people impacted by cancer by providing support, fostering compassionate communities, and breaking down barriers to care through education, research, and advocacy. counseling, support groups, and oncology Type: | 10 | 5 | 7 | 231 |
 | Cell Press Cell Press publishes over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies. Our story began over 45 years ago with the journal Cell and a commitment to publishing exciting biology. Today, we are bringing our editorial excellence, commitment to innovation, unparalleled reach and visibility, and passion for advocacy to all areas of scientific exploration as we work to publish and share science that inspires. To learn more, visit www.cell.com/about. Publishing, Biomedical Journals, Life Science Journals, and Research Reviews Type: | 25 | 6 | 15 | 394 |
 | Basilea Pharmaceutica For the benefit of patients Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: … Type: | 1 | 1 | 0 | 215 |
 | BioCurious BioCurious? Experiment with friends! BioCurious is a non-profit collaborative science space for lab work, social events and classes. Opportunities exist for volunteers interested in creating events and biology classes or in fundraising and outreach. We couldn't do it without your support. Join us today! Type: | 1 | 0 | 0 | 15 |
 | Array BioPharma Inc. Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC. Small molecule drug discovery and development., oncology, biotechnology, melanoma, and colorectal cancer Type: | 2 | 2 | 0 | 109 |
 | The Pharmaceutical Managers Institute We strive to support our members ongoing learning, growth and professional development in a rapidly evolving industry. The PMI is a professional membership organisation dedicated to the continuous learning, development and support of those working in management within the pharmaceutical industry. Our membership is diverse, covering Commercial, Marketing, Market Access, Product Management and Regulatory roles; representating over 80 pharmaceutical organisations. The Institute has been built on 3 pillars, which are central to all the events and activities we run throughout the year. With our four different event series - Pharma Leaders, Pharma Managers, Women in Leadership and Masterclasses - we … Type: | 27 | 0 | 27 | 11 |
 | Zinc One Resources Inc. Zinc One is a Vancouver based company focused on the acquisition, exploration and development of prospective and advanced world class zinc projects. | 0 | 0 | 0 | 2 |
 | GenScript Make People and Nature Healthier through Biotechnology Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 200,000 customers from over 100+ countries and regions worldwide have used GenScript’s premier, convenient, and reliable products and services. GenScript has over 6,900 employees globally, with about 10% R&D personnel. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis, and bioinformatics, including more than 300 patents and about 900 … Type: | 11 | 2 | 8 | 985 |
 | NewBiologix Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders. Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies. gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, and human cell lines Type: | 0 | 0 | 0 | 23 |
 | Enzymatica AB Enzymatica is a life science company whose business concept is to offer effective aid against some of our most common diseases where viruses or bacteria play a decisive role. Over a short period the company has developed a unique oral spray for common colds, ColdZyme® and launched it on four markets. The product became the leading article for common cold in Swedish pharmacies during winter 2014-2015. For product inf, please visit at www.coldzyme.co.uk. The development program includes medical devices in upper respiratory infections and oral health, and veterinary products. Cold and Flu, Enzyme (trypsin), and Barrier technology Type: | 0 | 0 | 0 | 25 |
 | Altamira Therapeutics Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets. Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhoreTM / SemaPhoreTM delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. Additionally, the Company is in the process of divesting and/or out-licensing its legacy assets in allergology and viral infections and inner ear therapeutics. The Company was founded in 2003, under the name Auris Medical, and is headquartered in Hamilton, Bermuda with its main operations in Basel, … Type: | 0 | 0 | 0 | 13 |
 | SphingoTec Improving patient outcomes with innovative diagnostics for acute care: Actionable insights in real-time SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies. Furthermore, sphingotec develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases and breast cancer, in order to support prevention strategies. SphingoTec GmbH was established in 2002 by Dr. Andreas Bergmann was one of the founders of B.R.A.H.M.S. AG. As former Chief Research Officer, he was responsible … | 0 | 0 | 0 | 30 |
 | Summit Pharmaceuticals International Corporation As one of core operating companies of the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of the health and well-being by linking pharmaceutical companies in Japan and overseas, leveraging its global network and expertise. Type: | 1 | 1 | 0 | 34 |
 | FUJIFILM Cellular Dynamics, Inc The Power of Human Biology: Leveraging our human iPSC technology to revolutionize scientific research and cell therapy. Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development. induced pluripotent stem cells (iPS cells), human tissue cells, cardiomyocytes, endothelial cells, custom iPS cell lines, neurons, dopaminergic neurons, skeletal myoblasts, hepatocytes, hematopoietic progenitor cells, cardiac progenitor cells, and astrocytes Type: | 7 | 1 | 4 | 220 |
 | Xeris Pharmaceuticals, Inc. We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies. | 3 | 0 | 2 | 397 |
 | RayBiotech #Biotech company offering #proteomics detection tools since 2001. #Research news, promos, & blogs. #Biomarkers #CRO RayBiotech is a leading life sciences company providing proteomic discovery tools to scientists in 85 countries worldwide. RayBiotech is committed to accelerating research through innovation, leadership, and excellent products and service. Protein Immunoassays, ELISA Kits, Antibody Arrays, Glycoscience, Protein Arrays, Immunological Assays, Antibody Development, Assay Development, Custom Protein Expression, Statistical Analysis, CRO Services, Flow cytometry, Recombinant proteins, Aptamers, Phosphorylation, Biostatistics, and Bioinformatics Type: | 0 | 0 | 0 | 63 |
 | uniQure Transforming the lives of patients through gene therapy uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases. aav and lpl Type: | 2 | 2 | 0 | 377 |
 | Merck India Merck is a leading science & technology company in the business of healthcare, life science & electronics. We are Merck, the vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. As a leading science and technology company, Merck operates across healthcare, life science and electronics. Our employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases … Type: | 1 | 0 | 1 | 531 |
 | Cluster Campania Bioscience Campania Bioscience is the regional cluster operating in the filed of Life Sciences Campania Bioscience is a regional cluster gathering together competences and facilities in the fields of Health, Biotech and Agro-food with the aim of valorizing the partners expertise in terms of value chain. The cluster is composed of 7 research entities, 51 companies and 2 Technology Transfer agencies. Networking and knowledge transfer are considered key assets to leverage competitiveness, entrepreneurship and innovativeness. The Cluster operates within: CEBR, European Biotechnology Network; ALISEI - Italian cluster on life sciences. Beneficiary of INNOSUP 2015-1, for the provision of advanced support to … Type: | 2 | 1 | 2 | 6 |
 | Merqurio Insieme per comunicare Merqurio: closer to customers, closer to market Books, services, relationships and marketing on behalf of public and private healthcare systems: increasingly competitive and fragmented markets require quick and effective actions. Innovation or tradition? Is communication to explore new technologies or rely on traditional channels? Marketing and sales operations are facing new challenges from the pharmaceutical market. The goal is to optimize contacts and relationships and create value by reducing costs. Merqurio provides pharma companies and national health system with new ways of interacting with doctors and pharmacists through their own media and publishing experience in marketing pharmaceutical … | 11 | 0 | 11 | 199 |
 | Value Edge Value Edge Research is a global business research, market intelligence, market research and sales analytics company providing support and outsourcing solutions to global bio-pharma companies. We are known for the high quality of our deliverables driven by a highly talented and experienced team from blue chip life science companies and life science solution providers. The firm's custom research and analytics and proprietary research reports and databases to global life science clients are highly cost effective. Value Edge is headquartered in India and the US office is located in the Greater Boston Area. For more information on Value Edge and its … Type: | 21 | 2 | 7 | 20 |
 | Cognixion Cognixion is making XR accessible for all. #BCI #AR #AssistedReality The Assisted Reality company (AR+BCI) CognixionTM is building the world's most accessible AR (#Assisted Reality) wearable device with integrated brain computer interface technology (#BCI) as a wireless, wearable go-anywhere neural interface. Cognixion is based in Santa Barbara, California and Toronto, Ontario. It's solutions elegantly blend the power of artificial intelligence (A.I.), neuroscience (BCI) and augmented/assisted reality (AR). Cognixion is internationally recognized for its innovation and use of exponential technologies to solve a social and healthcare global challenge - affecting the lives of 509 million people unable to speak. Cognixion has … Type: | 8 | 1 | 8 | 42 |
 | Pharmacy2U Ltd We are the UK's largest online pharmacy, proudly serving over 1.4 million patients across the Pharmacy2U group Pharmacy2U is the UK’s largest digital pharmacy serving over 1.5 million patients across the Pharmacy2U group. Its mission is to make healthcare more accessible, providing choice and convenience for the whole family when managing health and well-being. Founded in 1999, and a trusted NHS partner since 2001, Pharmacy2U has revolutionised the repeat prescription industry. Based in Leeds and Bardon, it is a multi-award-winning business, with patient care at the forefront, supported by 420,000+ reviews and an excellent Trustpilot rating. Pharmacy2U offers a wide … | 10 | 2 | 8 | 374 |
 | Sam Small Recruitment Ltd Sam Small – Healthcare Communications Jobs Sam Small is a recruitment agency specialising in providing healthcare communications jobs to candidates primarily within London and South-East of England. We supply our candidates with healthcare advertising and PR jobs mainly in account management at all levels of healthcare communications. For candidates with suitable experience, we have a range of medical education jobs from editing to writing and account management. Whether you are a medical writer or an account director, we will do our best to find the right job for you. Every job interview involves time and energy. At Sam Small Recruitment … Type: | 3 | 0 | 3 | 4 |
 | Humanigen, Inc. Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralization and gene-knockout platforms. Its proprietary Humaneered® monoclonal antibodies, designed to optimize antibody properties, show promise in prevention/treatment of cytokine storm induced by SARS-CoV-2 (COVID-19), chimeric antigen receptor T-cell (CAR-T) therapy and graft versus host disease (GvHD) by neutralizing GM-CSF which is up-regulated in these conditions. Type: | 4 | 0 | 3 | 6 |
 | Oxford BioTherapeutics Redefining the cancer-immune synapse for novel immune checkpoint mechanisms Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies designed to fulfil major unmet patient needs in cancer therapeutics. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. OBT076's dual mechanism of action allows it to act as a 'primer' to re-engage the patient's immune system while at the same time targeting cancer cells directly. OBT’s proprietary OGAP® target discovery platform … Type: | 1 | 0 | 1 | 48 |
 | Josep Carreras Leukaemia Research Institute International research Institute that pursues to study and eradicate Leukaemia, Lymphoma, and other Hemopathies. The Josep Carreras Leukaemia Research Institute was founded in 2010, by the Josep Carreras Foundation and the Government of Catalonia, as the first European research centre devoted exclusively to leukaemia and other malignant blood diseases, and one of the few that exist in the world. We investigate basic, epidemiological, preventive, clinical, and translational aspects of leukaemia and other hematologic malignancies. Our research aims to identify new therapeutic targets and enable us to develop more precise and less aggressive treatments. We aspire to understand the origin and … Type: | 14 | 4 | 9 | 250 |
 | Cerapedics Inc. Cerapedics is an Orthopedics company aspiring to redefine the standard of care for bone repair. Cerapedics is a global, commercial-stage orthopedics company that aspires to redefine the standard of care for bone repair by healing bones faster and at higher rates, without compromising safety, so that patients can live their healthiest lives. Bone grafts, including Cerapedics’ products, are used in over four million annual spine, orthopedics, trauma and interventional procedures world-wide. Cerapedics’ product, i-FACTOR®, is FDA approved for single-level cervical spinal fusions in the United States. Cerapedics’ next-generation product is currently being evaluated for use in lumbar interbody fusion through … Type: | 1 | 1 | 0 | 208 |
 | Ostick + Williams Ostick + Williams Ltd, established in 1951, is an award winning architectural practice and is at the forefront of BIM adoption within the UK and Ireland. This is evidenced by our recent award for Best Implementation of Level 2 BIM (2016) and our achievement of BRE BIM Level 2 Business Systems Certification. We have architectural experience that covers a wide range of building types and a strong portfolio of projects has been built up in the sciences, education, retail, office, production and leisure sectors. Our goal is to produce buildings of character which are elegant, functional and cost effective. We … Type: | 1 | 0 | 1 | 32 |
 | Fera Science Ltd. Original thinking...Applied. Our vision is to support our partners to respond to the challenges ahead through original thinking and world class science. Fera Science Limited (Fera) is a trusted partner of industry and government for over 100 years. With population growth, environmental change, food security and safety and political uncertainty impacting all areas of the agri-food chain across the globe now and for the foreseeable future. Our mission is to respond to these challenges by supporting our partners to develop new products and services across the agri-food chain improving global food security, sustainability and safety. Food safety and quality, Understanding … Type: | 8 | 2 | 5 | 483 |
 | atg Evoqua Experts in chemical-free water treatment With 35 years of passion & expertise in water treatment, we are industry experts in environmentally friendly & chemical-free UV Treatment & related technologies With industry regulations becoming more stringent and the increasing threat of chemically resistant strains of micro-organisms, it is important to choose a UV system manufacturer who you can trust. With state-of-the-art technology and a wealth of industry experience, atg UV have the expertise to provide effective, cost efficient and validated (US EPA UVDGM & DWI 2010 Guidelines) Ultraviolet disinfection and treatment solutions for a vast range of applications, treating flows of … Type: | 0 | 0 | 0 | 13 |
 | Biden Cancer Initiative The Biden Cancer Initiative is determined to bring urgency to the fight against cancer and to transform cancer research and care systems for the 21st century. The Initiative brings to life Vice President Joe Biden and Dr. Jill Biden’s vision of a day when we can effectively prevent, diagnose, treat and care for every cancer patient. We are an independent nonprofit organization that builds on the Cancer Moonshot’s goals and impact and that channels what we learned from that effort into programs that will make a real difference in the lives of patients for generations to come. collaboration, data sharing, … Type: | 7 | 1 | 3 | 1 |
 | Fondation Inartis Innovate for Growth Foster Synergies Drive Change Fondation Inartis promotes innovation with programmes such as the labs & coworking spaces UniverCité and Espace Creation, the startup accelerator MassChallenge Switzerland and the life science cluster of the Health Valley. Innovation, Life Sciences, Startups, Technology, Entrepreneurship, Coworking, and Health Valley Type: | 9 | 2 | 7 | 5 |
 | Protein Sciences Corporation Protein Sciences (www.proteinsciences.com) is a biotechnology company that specializes in vaccine development and protein production. Our mission is our inspiration: to save lives and improve health by effectively responding to the changing world through the creation of innovative vaccines and biopharmaceuticals. See where Flublok® Influenza vaccine is available at www.flublok.com. We use our proprietary BEVS protein expression technology to produce high quality recombinant proteins quickly, reliably and at low cost. We have developed three main business lines that employ this technology: 1. Proprietary vaccines - we develop and produce the next generation of safer and more effective vaccines 2. GeneXpress® … Type: | 1 | 1 | 0 | 46 |
 | Center for Computational Imaging & Simulation Technologies in Biomedicine (CISTIB) Who We Are Led by Professor Alejandro Frangi, Professor of Biomedical Image Computing in the Department of Mechanical Engineering, CISTIB is a research group with 29members comprising 3 academics, 2 Research Fellows, 6 Research Associates, 3 Scientific Software Developers, 10 PhD Students and 5 Professional Support Staff. What We Do CISTIB performs cutting-edge research in areas of fundamental and applied biomedical imaging and modelling with impact in personalised minimally-invasive therapies and active and healthy ageing. Our team has an international and interdisciplinary profile and has a strong commitment to clinical and industrial translation with impact in future healthcare. CISTIB focuses … Type: | 0 | 0 | 0 | 7 |
 | Euromedice Vivactis Spain We provide knowledge and innovation to achieve excellence in all our projects. EUROMEDICE is a multi-channel medical publishing house founded more than 20 years ago. We are specialized in the creation and development of scientific content projects published in any type of medium; printed, web, app, in person,... We are a company made up of a team of 28 people, mostly graduates and with a turnover of approximately 10 million euros. Our clients are mainly pharmaceutical companies, scientific societies and public administrations. Our headquarters are in Spain, with offices in Madrid and Barcelona. Our vocation is to create innovative projects, … | 3 | 0 | 3 | 9 |
 | Moon Rabbit Through Crypto We Seek Immortality Moon Rabbit is a vertically integrated crypto-meritocratic techno-conglomerate — 安居財閥 (AngoZaibatsu) — constituting a system of systems (Jurisdictions) with the overarching mission of seeking to discover the secret to eternal life — whether biologically or digitally — and to enable humanity to transcend the known dimensions and experience new worlds and spiritual states. blockchain, cryptocurrencies, Ethereum, bitcoin, crypto, dlt, biotech, longevity, polkadot, and web3 Type: | 17 | 5 | 5 | 4 |
 | EMVO | European Medicines Verification Organisation Securing the legal supply chain from falsified medicines for patient safety in Europe. The European Medicines Verification Organisation “The European Medicines Verification Organisation (EMVO) is the guarantee of patient security in Europe.” The European Medicines Verification Organisation (EMVO) has taken responsibility for advancing the formation of the European Medicines Verification System (EMVS). The EMVS is in accordance with the EU’s Falsified Medicines Directive (FMD) and the Delegated Regulation (DR). It ensures the implementation of a functioning, secure, interoperable and cost effective system across Europe. The infiltration of falsified medicines in the European supply chain is a major and continuous threat … Type: | 4 | 1 | 3 | 30 |
 | IQTC The Institute of Theoretical and Computational Chemistry of the Universitat de Barcelona The Institute of Theoretical and Computational Chemistry of the Universitat de Barcelona (IQTCUB) is integrated by more than 60 researchers, experts in several fields of the Theoretical and Computational Chemistry. The research activity carried out at the IQTCUB covers methods and computational tools development, application of several techniques of electronic structures and simulation to problems in materials science, the study of reactivity and reaction dynamics in chemical reactions as well as of biological systems and soft-matter. The main goal is to generate synergies between researchers encouraging the interdisciplinary … Type: | 1 | 1 | 0 | 7 |
 | Zealand Pharma Changing lives with next generation peptide therapeutics Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on … Type: | 6 | 3 | 2 | 386 |
 | MIP Discovery nanoMIPs - synthetic antibodies with robust characteristics and secure supply Our proprietary technology includes a novel method to make nanoMIPs which circumvents the drawbacks of traditional MIP manufacturing methods. NanoMIPS are, as the name suggests, nanostructured polymer particles typically containing a single binding site for their target. They can also be fused to solid substrates, such as sensor surfaces, if required. The robust nature of MIPs and nanoMIPs make them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing. As they are synthetic polymers, MIPs can withstand harsh chemical environments such as extremes … Type: | 1 | 0 | 0 | 18 |
 | MONCYTE Health Unique technology and novel data for personalized and optimal treatment of high cholesterol MONCYTE Health has a unique proprietary technology to quantify individual differences in cellular lipid uptake and storage which contribute to high blood cholesterol and the effectiveness of common lipid-lowering drugs. The readouts are derived from white blood cells, including monocytes, which play key roles in atherosclerotic plaque formation and inflammation, linking directly to cardiovascular risk. Precisely quantifying these individual differences enables personalized treatment strategies in combination with risk assessment which can help patients more effectively achieve optimal blood cholesterol levels faster, and thereby reduce the risk for … Type: | 0 | 0 | 0 | 3 |
 | Agomab Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. Type: | 0 | 0 | 0 | 49 |
 | Lightcast Profiling function, cell by cell. Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics. Type: | 0 | 0 | 0 | 111 |
 | ThirtyFiveBio Applying proprietary understanding of GPR35 biology to develop novel small-molecule modulators. ThirtyFiveBio is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of GPR35. We are currently engaged in a fully enabled drug discovery program to identify novel small-molecule modulators of GPR35 Type: | 1 | 0 | 1 | 15 |
 | Celyad Oncology Developing Innovative Cell Therapies Against Cancer Celyad Oncology is a biotechnology company focused on the discovery and development of tecnhlologies and platform for chimeric antigen receptor T cell (CAR T) therapies. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs. For more information, please visit www.celyad.com. Immuno-Oncology, Cancer, Immnotherapy, shRNA multiplex, and CAR T-cells Type: | 0 | 0 | 0 | 44 |
 | Wageningen Environmental Research Welcome to Wageningen Environmental Research! Follow us for news and vacancies in the domain of environmental science. Wageningen Environmental Research (WENR) is a scientific knowledge institute that is part of Wageningen University & Research (WUR). Based on our scientific knowledge, we develop gnature-based solutions for spatial design issues. We work closely with the Department of Environmental Sciences, as well as the other knowledge institutes of WUR. Do you have a question, suggestion or reaction to our research, or do you want to explore opportunities for collaboration with us? Get in touch with our experts at https://www.wur.nl/en/Research-Results/Research-Institutes/Environmental-Research/Contact.htm. research, water, climate change, … Type: | 18 | 5 | 13 | 199 |
![Neutun Labs [Acquired by Doc.ai]](/media/logo/13163.jpeg){kind=logo} | Neutun Labs [Acquired by Doc.ai] We build data products that let people actualize their data. From their data to their wearables and smart devices, we connect it all in one central platform. From there, we can build better services and deliver it in a more human way. We'e create a utility that acts as a distributed ledger for a person's data. Data Science, Big Data, APIs, and informatics Type: | 10 | 2 | 6 | 36 |
SMB